摘要
目的:观察超短效人胰岛素类似物赖脯胰岛素(优泌乐,Lispro)与短效胰岛素诺和灵R(Novolin R)在强化治疗中的疗效差异。方法:60名2型糖尿病患者随机分为两组,胰岛素泵治疗1周,观察两组治疗前后不同时间点血糖值变化、达标时间、胰岛素用量及有无低血糖发生。结果:Lispro组较Novolink R组血糖达标时间短、胰岛素用量少、两组均未发生低血糖。结论:在胰岛素泵强化治疗中Lispro更具优势。
Objective： To observe the difference of therapeutic effect between supershort-effect insulin analog lispro and shorteffect insulin novolin R on diabetes patients, Method： Sixty type 2 diabetes mellitus patients were divided into two groups and received insulin pump therapy for 2 weeks. The plasma glucose at different time after therapy, period of reaching target, total insulin dosage and whether hypoglycaemia happened were observed. Result： Period of reaching target of Lispro group was shorter than novolin R group, and total insulin dosage was less than novolin R group. There were no hypoglycaemia happened in neither groups. Conclusion： Lispro had an advantage comparing with novolin R in insulin pump intensification therapy.
出处
《中国药师》
CAS
2007年第5期487-488,共2页
China Pharmacist
